We are international
Donate
• health professionals TEXT SIZE   


Dr. Reeder - Phase II Trial of Myeloma Induction Therapy with Cyclophosphamide, Bortezomib, and Dexamethasone (Cybor-D): Improved Response over Historical Lenalidomide-Dexamethasone Controls
Craig B. Reeder, MD
Mayo Clinic
Scottsdale, Arizona
12.23.07


To view the video full screen, click on the small button next to the volume control in the lower right hand corner.


 related articles